Your browser doesn't support javascript.
loading
Giant retroperitoneal liposarcoma with multiple organ involvement: a case report and literature review.
Sun, Jia-Ning; Yang, Rui; Jiang, Xiao-Lu; Zhang, Feng; Zhao, Hong-Wei.
Affiliation
  • Sun JN; School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
  • Yang R; School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
  • Jiang XL; Affiliated Yantai Yuhuangding Hospital of Qingdao University, No. 20 East Yuhuangding Road, Yantai, 264000, Shandong, China.
  • Zhang F; Second Clinical Medical College, Binzhou Medical University, Yantai, China.
  • Zhao HW; Affiliated Yantai Yuhuangding Hospital of Qingdao University, No. 20 East Yuhuangding Road, Yantai, 264000, Shandong, China. 15153578806@126.com.
BMC Nephrol ; 25(1): 281, 2024 Aug 29.
Article in En | MEDLINE | ID: mdl-39210338
ABSTRACT

BACKGROUND:

Retroperitoneal liposarcoma (RPLPS) is a relatively rare disease. Liposarcomas vary in size, but sizeable RPLPS larger than 30 cm in diameter are very rare, and their diagnosis and treatment present significant challenges. CASE PRESENTATION We report a 58-year-old male patient who was admitted to the hospital with an increased abdominal circumference and was later diagnosed with a giant RPLPS. The liposarcoma was found to adhere to the right kidney and the entire ureter, invading the ascending colon. The patient underwent complete combined surgical resection. The tumor was removed intact, measured 55.0 cm × 30.0 cm × 18.0 cm, and weighed 19.8 kg. Histopathologic analysis revealed well-differentiated liposarcoma (WDLPS). The patient was successfully discharged from the hospital and followed up for 6 months with no signs of recurrence.

CONCLUSION:

RPLPS is a rare tumor with atypical clinical presentation. Surgery remains the most effective method of treatment for retroperitoneal sarcomas, with complete removal if there is local invasion. Preoperative examination, including three-dimensional (3D) reconstruction, is essential for surgical success. The role of adjuvant radiotherapy or chemotherapy remains controversial. However, clinicians should not rule them out as viable options.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retroperitoneal Neoplasms / Liposarcoma Limits: Humans / Male / Middle aged Language: En Journal: BMC Nephrol Journal subject: NEFROLOGIA Year: 2024 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retroperitoneal Neoplasms / Liposarcoma Limits: Humans / Male / Middle aged Language: En Journal: BMC Nephrol Journal subject: NEFROLOGIA Year: 2024 Type: Article Affiliation country: China